|
Addition patient comorbidities: hypertension, benign prostatic hyperplasia, asthma, gerd, hypercholesterolemia, aaa, and colonoscopy addition patient medications: plavix, albuterol, aspirin, atorvastatin, hydrochlorothiazide, lisinopril, metoprolol, and flonase.
|
|
Addition g4/g5.Addition the device was returned to gore for evaluation.The device evaluation showed the leading end is detached from the rest of the device.The polyimide length of the detached section is approximately 4 cm from the tip of the leading olive and detached at the mid olive.Approximately 4cm of polyimide was not returned for evaluation.The mid-olive is still attached to the polyimide and appears to be intact with no visible defects.A portion of the polyimide can be observed at the mid-olive transition.Based on the findings from this evaluation, the physician¿s observation that the leading end had become completely detached, was confirmed.The polyimide was separated at the mid-olive transition of the catheter.The likely cause for the separated guidewire polyimide lumen could not be determined with the available information.
|